Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Carlsmed (CARL) Operating Expenses (2024 - 2025)

Carlsmed's Operating Expenses history spans 2 years, with the latest figure at $20.9 million for Q4 2025.

  • For Q4 2025, Operating Expenses rose 78.53% year-over-year to $20.9 million; the TTM value through Dec 2025 reached $67.0 million, changed N/A, while the annual FY2025 figure was $68.6 million, 55.34% up from the prior year.
  • Operating Expenses reached $20.9 million in Q4 2025 per CARL's latest filing, up from $19.0 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $20.9 million in Q4 2025 to a low of $10.9 million in Q2 2024.